Publicaciones en colaboración con investigadores/as de University Hospital of Zurich (3)

2023

  1. Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study

    European Journal of Cancer, Vol. 195

  2. Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

    Nature Reviews Clinical Oncology, Vol. 20, Núm. 6, pp. 372-389

2016

  1. The SafeBoosC phase II clinical trial: An analysis of the interventions related with the oximeter readings

    Archives of Disease in Childhood: Fetal and Neonatal Edition, Vol. 101, Núm. 4, pp. F333-F338